InvestorWire NewsRoom

InvestorNewsBreaks

Tuesday Apr 01, 2025 - 1:25 pm

InvestorNewsBreaks – Fifty 1 Labs Inc. (FITY), Genetic Networks Set to Push the Boundaries of Biotechnology 

Fifty 1 Labs (OTC: FITY), a forward-thinking leader in biotechnology and health innovation, today announced a groundbreaking achievement by its recently acquired subsidiary, Genetic Networks, in space-based biotechnology. The milestone stems from over a decade of space-based functional genomics from Dr. Corey Nislow's laboratory, with the work highlighting the pivotal role of functional genomics in diverse aspects of human health and wellness. According to Dr.…

Continue Reading

Tuesday Apr 01, 2025 - 11:30 am

InvestorNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Surpasses 800 Advertisers, Maintains 243% CAGR Amid Rapid Expansion

Thumzup (NASDAQ: TZUP), a rising AdTech player in social media branding and programmatic marketing, announced it has exceeded 800 advertisers on its platform, with expectations to cross 1,000 by mid Q2 2025. The company reported a 243% compound annual growth rate, fueled by strategic expansion into South Florida, Miami, and Greater Salt Lake City. Thumzup’s platform integrates with major social networks, including Instagram Reels and…

Continue Reading

Tuesday Apr 01, 2025 - 10:15 am

InvestorNewsBreaks – XTI Aerospace Inc. (NASDAQ: XTIA) Closes $4 Million Public Offering to Repay Debt and Fund Operations 

XTI Aerospace (NASDAQ: XTIA), a developer of vertical takeoff and landing (“VTOL”) aircraft, has closed a public offering of 2,941,200 shares of common stock (or pre-funded warrants) and an equal number of accompanying warrants at a combined offering price of $1.36 per unit. The five-year warrants are immediately exercisable at the same price. Gross proceeds totaled approximately $4 million before expenses, which the company will…

Continue Reading

Tuesday Apr 01, 2025 - 10:09 am

InvestorNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Acquires Skytech to Expand AI Robotics in Hospitality Sector 

Nightfood Holdings (OTCQB: NGTF), an innovator in hospitality automation, has acquired Skytech Automated Solutions, Inc., a leader in AI-driven service technologies for hotels. This strategic move follows Nightfood’s recent acquisition of Carryout Supplies and enhances its Robotics-as-a-Service (RaaS) offerings. Skytech’s Laundry Helper robot, already in use at multiple hotel properties, will now be integrated into Nightfood’s broader automation platform to improve operational efficiency and guest…

Continue Reading

Tuesday Apr 01, 2025 - 10:00 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position

CNS Pharmaceuticals (NASDAQ: CNSP) a biopharmaceutical company targeting brain and CNS cancers, reported a full-year 2024 net loss of $14.9 million, down from $18.9 million in 2023, due to reduced R&D spending. Despite Berubicin missing its primary endpoint in a glioblastoma multiforme (GBM) trial, the drug demonstrated safety and comparable efficacy, guiding future analysis. The company is shifting focus to TPI 287, a candidate with…

Continue Reading

Tuesday Apr 01, 2025 - 9:52 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Reports $10.8 Million Revenue in 2024, Advances 

Knightscope (NASDAQ: KSCP), a developer of autonomous security robots and AI-driven technologies, reported $10.8 million in revenue for fiscal 2024, down from $12.8 million in 2023 due to product line restructuring. Despite a net loss of $31.7 million, the company strengthened its cash position to $11.1 million through $34.5 million in capital raises. Knightscope achieved major milestones including FedRAMP Authority to Operate, its first K5…

Continue Reading

Tuesday Apr 01, 2025 - 9:50 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference on April 9

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company advancing treatments for neurodegenerative diseases like ALS and MS, will present at the Jones Healthcare and Technology Innovation Conference on April 9, 2025, at 11:30 a.m. PT. The event will be held at the Venetian Resort in Las Vegas and include 1x1 investor meetings. A webcast of the presentation will be available via the events section of Clene’s…

Continue Reading

Tuesday Apr 01, 2025 - 9:40 am

InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $3.9 Million Offering to Advance Immunotherapy Programs

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted immunotherapies, closed its previously announced registered direct offering and concurrent private placement with a single institutional investor, raising approximately $3.9 million in gross proceeds. The offering included 3,325,000 shares of common stock and pre-funded warrants for 2,728,000 shares, along with Series G warrants for 6,053,000 shares. Proceeds will support working capital and advance Calidi’s…

Continue Reading

Tuesday Apr 01, 2025 - 9:34 am

InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Launches CA$1.4 Million Private Placement to Fuel U.S. Growth 

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and privacy communications provider, announced a non-brokered private placement to raise up to CA$1.4 million (US$1 million). The offering includes up to 40,000,000 units priced at CA$0.035 each, with each unit consisting of one common share and one full warrant exercisable at CA$0.05 for 24 months. Proceeds will support U.S. marketing efforts for…

Continue Reading

Tuesday Apr 01, 2025 - 9:30 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Completes Data Collection for Deep Imaging Survey at Montauban 

ESGold (CSE: ESAU) (OTCQB: ESAUF) has completed data acquisition for its Ambient Noise Tomography survey at the Montauban Project, with geophone recovery now underway. Initial readings surpassed expectations, capturing subsurface data to depths exceeding 800 metres—double the original 400-metre target. The resulting 3D model, expected by month-end, will integrate seismic, geological, and geochemical data to guide drill targeting and reduce exploration risk. This marks the…

Continue Reading

Tuesday Apr 01, 2025 - 9:30 am

InvestorNewsBreaks – Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Files 2024 Annual Report, Sets May 9 Shareholder Meeting

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) filed its Form 40-F with the SEC, including audited financial statements for 2024, now available via EDGAR and the company’s website. The company also announced it will host its Annual and Special Meeting of Shareholders on May 9, 2025, at 10:30 a.m. PT. Shareholders may attend in person at Wheaton’s Vancouver office or virtually via the provided TSX…

Continue Reading

Tuesday Apr 01, 2025 - 9:21 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets $50 Million 2026 Revenue Target, Secures $15 Million in Financing to Advance Web 3.0 Data Monetization 

Datavault AI (NASDAQ: DVLT), a leader in AI-powered data monetization and valuation, issued a shareholder letter outlining a $40–50 million revenue goal for 2026 and disclosed $15 million in secured convertible debt financing. Proceeds will support strategic initiatives including IP portfolio expansion and asset acquisitions from CompuSystems. The company also spotlighted its presence at CES 2025 and partnerships with NYIAX, IBM, and Dolby, positioning itself…

Continue Reading

Tuesday Apr 01, 2025 - 9:20 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Partners with Mass General on PET Imaging Study for Multiple Sclerosis

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company advancing innovative biotech assets, announced a joint clinical study with Massachusetts General Hospital to evaluate a novel PET imaging technique for tracking myelin integrity in multiple sclerosis (MS) patients. The study will assess [18F]3F4AP PET scans as a biomarker for demyelination, complementing MRI scans in both progressive and relapsing-remitting MS. The technique may enhance diagnostics in trials involving remyelinating…

Continue Reading

Tuesday Apr 01, 2025 - 9:15 am

InvestorNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Initiates Maiden Resource Estimate at Duquesne West Gold Project 

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) has retained APEX Geoscience Ltd. to conduct a Maiden Mineral Resource Estimate for its Duquesne West Gold Project in Quebec. The assessment will incorporate historic and recent drilling data, unsampled core, and AI-assisted modeling, with results expected in early Q2 2025. Emperor’s 2024 drilling prioritized near-surface, open-pit targets to rapidly build ounces, supported by a reinterpretation of the…

Continue Reading

Tuesday Apr 01, 2025 - 9:10 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches TONIX ONE™ Digital Platform to Transform Migraine Care

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company advancing innovative therapies, announced the launch of TONIX ONE™, a fully integrated digital platform designed to streamline migraine care. Built through partnerships with UpScript Telemedicine, ProModRx, Blink Health, and a leading symptom-tracking app, TONIX ONE connects patients with migraine specialists, facilitates e-prescriptions, and accelerates treatment access. The platform offers educational tools and real-time support to help patients overcome…

Continue Reading

Tuesday Apr 01, 2025 - 9:00 am

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Honors Advisory Board Member Giuseppe Rossi at Fiorentina’s Pepito Day Tribute

Brera Holdings (NASDAQ: BREA), an Ireland-based company advancing a multi-club ownership model in global football, celebrated the legacy of Advisory Board member and former Italy international Giuseppe Rossi during Fiorentina’s Pepito Day on March 22 in Florence. The tribute at Stadio Artemio Franchi featured tributes from fans, football legends, and Rossi’s former coaches, recognizing his career-defining moments and contributions to the sport. Brera’s executive team…

Continue Reading

Monday Mar 31, 2025 - 3:25 pm

InvestorNewsBreaks – Harvest Communications, DealFlow Events to Showcase Intersection of Nuclear Energy and Innovation at Inaugural Discovery Day 

Harvest Communications, a full-service communications and content creation agency, building trust through compelling narratives and authentic brand stories, was named the Official Marketing Partner for DealFlow Events' Discovery Day on Nuclear Energy. Set to take place in New York City on May 22, 2025, the event will provide a platform for exploring investment opportunities and fostering connections among key stakeholders in the nuclear energy sector,…

Continue Reading

Monday Mar 31, 2025 - 1:50 pm

InvestorNewsBreaks – MoneyShow’s Virtual Expo Lineup to Unlock Profitable Strategies

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, has announced the upcoming “Income, Growth, and Value Virtual Expo,” which is slated to take place on Apr. 29-30, 2025. “Markets have experienced increased volatility due to the announcement of sweeping tariffs, retaliatory measures from trading partners, stubborn inflation metrics, and more. However, the tumult in the markets and…

Continue Reading

Monday Mar 31, 2025 - 1:47 pm

InvestorNewsBreaks – IBN to Drive Coverage for ZJ Events’ 2025 Expo Series 

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced its collaboration with ZJ Events LLC as the media sponsor in 2025 for the multi-location Alternative Products Expo (“Alt Pro Expo”) series across North, Latin and South America and the BizCann Expo in Medellin, Colombia. For these events, IBN will leverage sophisticated communications tools to optimize virtual coverage and broadcast live updates to…

Continue Reading

Monday Mar 31, 2025 - 10:54 am

InvestorkNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Completes Safety Lead-In for Phase 2 Prostate Cancer Trial 

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced completion of the safety lead-in for its Phase 2 trial evaluating ENV105 in combination with apalutamide for metastatic, castration-resistant prostate cancer. The trial will now proceed with patient randomization to assess apalutamide alone versus the combination therapy. Safety and efficacy data from the lead-in phase are expected in the first half of 2025. The company is…

Continue Reading

Monday Mar 31, 2025 - 10:30 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Defeats Motion to Dismiss in Spoofing Lawsuit

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced a key legal victory after a federal court denied a motion to dismiss its spoofing lawsuit against IMC Financial Markets, Clear Street Markets LLC, UBS Securities LLC, and others. The lawsuit alleges that defendants used high-frequency algorithmic trading tactics—including “Baiting Orders”—to manipulate Mullen’s stock price between Nov. 2021 and Nov. 2023. The court found sufficient evidence…

Continue Reading

Monday Mar 31, 2025 - 10:05 am

InvestorNewsBreaks – GivBux Inc. (OTC: GBUX) Plans $212 Million Equity Sale Through Non-Dilutive Structure

GivBux (OTC: GBUX), a publicly traded Super App and charitable giving platform, announced plans to sell a 30% equity stake for $212 million through a non-dilutive transaction aimed at preserving shareholder value. Proceeds will be invested in an income-focused strategy led by a private credit asset manager specializing in real estate, with the goal of generating steady cash flow to fuel the company’s platform expansion.…

Continue Reading

Monday Mar 31, 2025 - 9:34 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Drug Toward FDA Decision 

Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining attention as it advances TNX-102 SL, a non-opioid investigational therapy for fibromyalgia, toward potential FDA approval by Aug. 15, 2025. The drug, designed to treat chronic pain and sleep disturbances without addiction risks, targets widespread pain and fatigue associated with fibromyalgia—an area where existing treatments like Cymbalta and Lyrica have left many patients dissatisfied. With a sublingual bedtime dose…

Continue Reading

Monday Mar 31, 2025 - 9:30 am

InvestorNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Reports 887% Full-Year Revenue Growth and Expanded Tour Presence 

Newton Golf Company (NASDAQ: NWTG), a leader in premium golf equipment innovation, reported fourth quarter revenue of $1.07 million, up 817% from the prior year, and full-year revenue of $3.45 million, marking an 887% year-over-year increase. The company also doubled its gross margin to 67% in 2024, fueled by enhanced manufacturing and an improved product mix. Newton Golf, formerly Sacks Parente Golf, highlighted global retail…

Continue Reading

Monday Mar 31, 2025 - 9:10 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Closes $5 Million Offering to Advance Drug Development

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company, announced the closing of its final tranche in a debenture unit offering, raising a total of CAD $5 million. Proceeds will support research and development, commercialization efforts, and working capital, with management stating the funding provides runway through the first quarter of 2027. The company also began developing a hospital-use formulation of rekvry™, its alcohol misuse treatment designed to…

Continue Reading

Monday Mar 31, 2025 - 9:00 am

InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Closes CA$237,106 Private Placement to Support U.S. Expansion

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and privacy communications platform, announced the closing of the final tranche of its non-brokered private placement, raising gross proceeds of CA$237,106. The offering included 6,973,705 units priced at CA$0.034, each consisting of one common share and one full warrant exercisable at CA$0.055 for 24 months. Company insiders, including the CEO, CFO and a…

Continue Reading

Friday Mar 28, 2025 - 3:21 pm

InvestorNewsBreaks – Titan Partners Group LLC Acts as Sole Bookrunner for $10.5M Underwritten Offering 

Titan Partners Group, a division of American Capital Partners LLC, is acting as sole bookrunner for an underwritten offering of Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company. Genelux recently announced pricing of the offering, which consists of 3,000,000 shares of its common stock, each at an offering price of $3.50. Genelux expects approximately $10.5 million in gross proceeds from the offering, of which…

Continue Reading

Friday Mar 28, 2025 - 3:19 pm

InvestorNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Develop 7.2 MW Hoadley Hill Rd Solar Project 

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has announced plans to develop a 7.2 MW DC ground-mount solar power project known as the Hoadley Hill Rd project (the “Project”) on a site located in upstate New York. According to the announcement, the Project is another key addition to SolarBank's expanding development pipeline—which exceeds one gigawatt—as well as the…

Continue Reading

Friday Mar 28, 2025 - 2:05 pm

InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience

Upstream published a blog today that discussed ongoing efforts to enhance the trading experience via its innovative platform. The latest upgrade to Upstream’s KYC (Know Your Customer) identity verification process makes it more intuitive and seamless for users. The redesigned interface ensures a smoother experience while maintaining quick and secure verification, which is essential for preventing fraud and illicit activity. Users are prompted to complete…

Continue Reading

Friday Mar 28, 2025 - 11:35 am

InvestorNewsBreaks – Zacks Maintains $35.00 Price Per Share Valuation for Soligenix Inc. (NASDAQ: SNGX) Amid Promising Vaccine and CTCL Therapy Progress 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a recent Zacks Small-Cap Research report that presented a favorable analysis, emphasizing the company's advancements in vaccine and photodynamic therapy technologies.  The study highlights promising preclinical data for CiVax(TM), a thermostabilized COVID-19 booster, which demonstrated broad immune protection in non-human primates. Zacks also notes the continued progress of HyBryte(TM), Soligenix’s lead candidate…

Continue Reading

Friday Mar 28, 2025 - 10:04 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Q4 and Full-Year 2024 Financial Results, Highlights Breakthroughs in Alcohol Detox and MS Treatments 

Quantum BioPharma (NASDAQ: QNTM) reported its financial results for the fourth quarter and year ended Dec. 31, 2024, highlighting a strengthened balance sheet and strategic advances across its clinical programs. The company removed its Material Uncertainty Related to Going Concern, with $12.1 million in cash and a 36% reduction in net cash used for operations year over year. Operating expenses dropped over 32% to $16.1…

Continue Reading

Friday Mar 28, 2025 - 9:38 am

InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Announces $3.9 Million Registered Direct Offering and Private Placement 

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company advancing targeted immunotherapies, has entered into a securities purchase agreement with a single institutional investor for a registered direct offering of 3,325,000 shares of common stock at $0.65 per share, or pre-funded warrants in lieu of stock. Concurrently, the company will issue series G warrants to purchase up to 6,053,000 shares of common stock in a…

Continue Reading

Friday Mar 28, 2025 - 9:34 am

InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Gains Traction with Conference Participation and Analyst Coverage 

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, reported recent activity at major scientific gatherings and announced upcoming conference appearances. The company presented research on its GITR agonist KROS 101 at the Society for Immunotherapy of Cancer Spring Meeting on March 12, participated in BIO Europe from March 17 to 19, and will attend the Fierce Pharma Engage meeting in San Diego from April 29…

Continue Reading

Friday Mar 28, 2025 - 9:30 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Highlights CaSe Platform Acquisition in Weekly Update Focused on Early Cancer Detection

Aditxt (NASDAQ: ADTX), a social innovation platform focused on accelerating health technologies, announced that its latest Aditxt Weekly Update will spotlight the recent acquisition of the CaSe Platform by its subsidiary, Pearsanta, Inc. The proprietary technology, based on adductomics, is engineered to detect early DNA changes that could lead to cancer and other diseases. The discussion will emphasize how the CaSe Platform supports Pearsanta’s mission…

Continue Reading

Friday Mar 28, 2025 - 9:20 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces $1.7 Million Direct Offering to Support Working Capital

Knightscope (NASDAQ: KSCP), a developer of autonomous security robots and AI technologies, has entered into definitive agreements to sell 625,000 shares of common stock at $2.75 per share in a registered direct offering, expected to close on or about March 31, 2025. Gross proceeds are anticipated to total approximately $1.7 million before fees and expenses. H.C. Wainwright & Co. is acting as the exclusive placement…

Continue Reading

Friday Mar 28, 2025 - 8:45 am

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives NYSE Noncompliance Notice Over Market Cap and Equity Levels

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on therapies for neurodegenerative diseases, disclosed it received a noncompliance notice from the New York Stock Exchange on March 26, 2025, for falling short of continued listing standards under Section 802.01B. The notice stated that the company’s average global market capitalization over a 30-day period was approximately $37.9 million, while its stockholders’ equity as…

Continue Reading

Friday Mar 28, 2025 - 8:30 am

InvestorNewsBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Reports $47.6 Million Q4 Profit in First Full Quarter of Commercial Production

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) reported strong fourth quarter and full-year 2024 results, highlighted by 40,147 ounces of gold production and net income of $47.6 million, or $0.21 per share, in its first full quarter of commercial output from the Tocantinzinho Mine. All-in sustaining costs for the quarter were $862 per ounce, with adjusted EBITDA of $77.9 million and free cash flow…

Continue Reading

Thursday Mar 27, 2025 - 3:32 pm

InvestorNewsBreaks – Powered by Physics: Newton Golf Company’s (NASDAQ: NWTG) Rebrand Spotlights Game-Changing Technology

Newton Golf (NASDAQ: NWTG) has completed a strategic rebranding to emphasize its commitment to innovation and align more closely with its mission of integrating advanced physics principles into golf-equipment design. The restructuring was not merely a change in name but a reflection of Newton Golf’s dedication to creating equipment that leverages the laws of physics to benefit golfers of all skill levels. Central to the…

Continue Reading

Thursday Mar 27, 2025 - 2:55 pm

InvestorNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Forefront of Next-Gen Energy Storage

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is a frontrunner in lithium-sulfur battery innovation through its subsidiary, Lion Battery Technologies. By leveraging the unique properties of platinum and palladium, PLG is improving the efficiency and longevity of these batteries, which offer higher energy density, lower production costs, and environmental benefits compared to traditional lithium-ion batteries. With significant progress made in research, including testing at…

Continue Reading

Thursday Mar 27, 2025 - 12:35 pm

InvestorNewsBreaks – TransCode Therapeutics Inc. (NASDAQ: RNAZ) Secures $10M in Registered Direct Offering

TransCode (NASDAQ: RNAZ), the oncology company committed to utilizing RNA therapeutics to more effectively treat cancer, has announced the closing of its sale of 10,250,000 shares of its common stock and warrants to purchase up to 10,250,000 shares of common stock priced at-the-market under Nasdaq rules, at a purchase price of $0.98 per share and accompanying warrant. The company secured approximately $10 million in gross…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).